PieX AI, a global leader in multimodal AI hardware for smart health, is set to proudly…
Category: Insights
Psychedelic Drug Therapy May Address Mental Health Concerns in People with Cancer and Addiction
One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health…
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization
Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, and Mabgeek, a clinical-stage…
iXpressGenes Appoints John Schmitt as CEO, Announces Nationwide TAI Test Launch
iXpressGenes (iXG), a biotechnology company transforming trauma care, is proud to appoint co-founder John Schmitt as Chief Executive…
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies…
Dr. Joseph Russo – New treatment alert… Aveli and Ellacor have come to Dr Russo’s Office
The latest in proven cellulite correction and wrinkle reduction have arrived! NewBeauty Top Doctor, expert plastic surgeon Joseph…
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States
Zynex, Inc. (NASDAQ: ZYXI) (“Zynex”, “ZMS”, “we” or the “Company”), an innovative medical technology company specializing in the…
Precision for Medicine to Offer Spatial Biology Solutions Incorporating the PhenoCycler®-Fusion 2.0 System and the new Phenocode™ Discovery IO60 Panel from Akoya Biosciences
Precision for Medicine, a leading next-generation provider of drug development and commercialization services, today announced the…
Precision Biologics to Announce Development of New Monoclonal Antibody (mAb) PB-223 at SITC, Houston, TX, November 7-8, 2024
Precision Biologics, Inc. reports that affinity maturation and characterization of its novel anti-core 2 O-glycan monoclonal antibody…
Econologics Financial Advisors Announces Specialized Financial Services to Practice Associates
Econologics Financial Advisors (EFA), a trusted provider of personal financial planning services for healthcare practice owners,…